Cahill Represents Initial Purchasers in $1.5 Billion Notes Offerings for Bausch Health Companies Inc.
Date: 05/23/19
Cahill represented the initial purchasers in connection with concurrent Rule 144A offerings of $750,000,000 aggregate principal amount of 7.000% senior notes due 2028 and $750,000,000 aggregate principal amount of 7.250% senior notes due 2029 by Bausch Health Companies Inc., a multinational specialty pharmaceutical company. Proceeds from the offerings were used to fund the repayment of certain outstanding debt and to pay related fees, premiums and expenses.